手机版 客户端

自增敏型ROS触发释药的卟啉-紫杉醇“光化一体”小分子前药自组装纳米递药系统的研究

自增敏型ROS触发释药的卟啉-紫杉醇“光化一体”小分子前药自组装纳米递药系统的研究
  • 导航:首页 > 科学基金
  • 批准号:81703451
  • 批准年度: 2017年
  • 学科分类:药剂学(H3008) |
  • 项目负责人:罗聪
  • 负责人职称:博士后
  • 依托单位:沈阳药科大学
  • 资助金额:20.1万元
  • 项目类别:青年科学基金项目
  • 研究期限:2018年01月01日 至 2020年12月31日
  • 中文关键词: ROS;紫杉醇;光化;一体;纳米
  • 英文关键词:Combination therapy;“Two-in-One” prodrug;Prodrug nanoparticles;High-efficiency drug-loading;Co-deliv

项目摘要

中文摘要

尽管化疗协同光动治疗在抗肿瘤领域具有良好的临床应用前景,但如何实现化疗药和光敏剂的高效同步递送仍是一个亟待解决的难题。随着纳米递药系统的发展,将化疗药和光敏剂共载于纳米载体有望提高递送效率。然而,传统纳米载体的非共价共载方式存在载药量低、稳定性差和药物提前泄露等问题,且易导致光敏剂发生聚集淬灭效应。本项目拟设计合成光敏剂-化疗药“光化一体”小分子前药,构建自增敏型ROS触发释药的“光化一体”小分子前药自组装纳米递药系统。将焦脱镁叶绿素a和紫杉醇通过ROS敏感的单硫醚键共价连接,合成“光化一体”小分子前药,前药自组装形成纳米粒,实现焦脱镁叶绿素a和紫杉醇的高效共载和同步递送。激光照射下,光敏剂产生ROS进行光动治疗的同时,与肿瘤细胞内原有的ROS协同促进药物释放,纳米结构解体避免光敏剂的聚集淬灭效应,发挥高效的协同抗肿瘤作用。本项目的研究将为化疗药和光敏剂的高效共载和同步递送提供一种新思路。

英文摘要

Although the combination of chemotherapy and photodynamic therapy (PDT) has good potential application in the clinical treatment of cancer, how to realize efficient co-delivery of chemotherapeutic agents (CA) and photosensitizers (PS) for better synergistic effect is still a major challenge. Some drawbacks of the traditional nanocarriers used for non-covalent co-delivery of CA and PS have greatly limited their clinical application, such as low drug-loading efficiency, poor stability, significant drug leakage in systemic circulation postadministration, and limited PDT efficiency due to the quenching effect of PS trapped in nanocarriers. Herein, this project plans to synthesize porphyrin-paclitaxel (PTX) small-molecule prodrugs and prepare self-facilitated reactive oxygen species (ROS)-responsive prodrug-nanosystems assembled by the porphyrin-PTX prodrugs for chemo-photodynamic therapy. Pyrophaeophorbid a (PPa) is covalently conjugated to PTX using a thioether bond as ROS-responsive chemical linkage to obtain a “Two-in-One” prodrug (PPa-S-PTX). PPa-S-PTX can self-assemble into nanoparticles to realize efficient co-delivery of PPa and PTX with high drug-loading efficacy. In tumor cells, additional ROS produced by laser irradiation together with the intrinsic ROS overexpressed in tumor cells will synergistically facilitate drug release from prodrug nanoparticles. The prodrug nanoassemblies will be disintegrated along with drug release from PPa-S-PTX, resulting in improved synergistic combination of chemotherapy and PDT. This project will provide a new strategy for the rational design of prodrug-based drug delivery systems for high-efficiency co-delivery of CA and PS.

评估说明

    国家自然科学基金项目“自增敏型ROS触发释药的卟啉-紫杉醇“光化一体”小分子前药自组装纳米递药系统的研究”发布于爱科学iikx,并永久归类于相关科学基金导航中,仅供广大科研工作者查询、学习、选题参考。国科金是根据国家发展科学技术的方针、政策和规划,以及科学技术发展方向,面向全国资助基础研究和应用研究,发挥着促进我国基础研究源头创新的作用。国科金的真正价值在于它能否为科学进步和社会发展带来积极的影响。

此文由 爱科学 编辑!:首页 > 科学基金 > 科学基金4 » 自增敏型ROS触发释药的卟啉-紫杉醇“光化一体”小分子前药自组装纳米递药系统的研究

推荐文章